Protagenic Therapeutics' Seed Round

Protagenic Therapeutics raised a round of funding on February 02, 2012. Investors include Invus Group.

Protagenic Therapeutics is a biotechnology company focusing on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorder…

Articles about Protagenic Therapeutics' Seed Round: